Clinical Trial Update: Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sequential AG and mFOLFOX chemotherapy with serplulimab and bevacizumab in untreated advanced pancreatic cancer; currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Serplulimab (serplulimab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Non-Resectable Pancreas Carcinoma | Phase 2 | Status: RECRUITING